EcoDrugPlus

Collagenase 3-Like

Ensembl ID : ENSHCOG00000013269
Gene Symbol: LOC109531162
2 Cross references
277 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSHCOG00000016450
Gene Symbol: CSF1R
3 Cross references
63 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSHCOG00000018007
Gene Symbol: CRHR1
3 Cross references
207 Possible Orthologues:

Creatine Kinase, Testis Isozyme-Like

Ensembl ID : ENSHCOG00000011135
Gene Symbol: LOC109519547
2 Cross references
193 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSHCOG00000009089
Gene Symbol: CDK1
3 Cross references
247 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSHCOG00000019256
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSHCOG00000019741
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSHCOG00000005068
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSHCOG00000009338
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSHCOG00000015461
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSHCOG00000002494
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSHCOG00000003281
Gene Symbol: CYSLTR1
1 Cross references
176 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).